Brevan Howard Capital Management LP Ionis Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 28,479 shares of IONS stock, worth $968,570. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,479
Previous 21,847
30.36%
Holding current value
$968,570
Previous $1.04 Million
9.51%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$482 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$351 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$297 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$268 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.83B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...